Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

Immunity

Volumn 43, Issue 6, 2015, Pages 1186-1198

  Nakaya, Helder I ^a,b   Hagan, Thomas ^c   Duraisingham, Sai S ^d   Lee, Eva K ^e   Kwissa, Marcin ^f   Rouphael, Nadine ^g   Frasca, Daniela ^h   Gersten, Merril ^c   Mehta, Aneesh K ^b   Gaujoux, Renaud ⁱ   Li, Gui Mei ^b,g   Gupta, Shakti ^c   Ahmed, Rafi ^b,g   Mulligan, Mark J ^g   Shen Orr, Shai ⁱ   Blomberg, Bonnie B ^h   Subramaniam, Shankar ^c,j,k,l   Pulendran, Bali ^b,g  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e Georgia Institute of Technology   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g EMORY UNIVERSITY   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INFLUENZA VACCINE; MICRORNA; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TRANSCRIPTOME; VIRUS ANTIBODY;

AGE; ANTIBODY RESPONSE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CORRELATIONAL STUDY; GENDER; GENE CONTROL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VACCINATION; INNATE IMMUNITY; LONGEVITY; LYMPHOCYTE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RACE; SEASONAL INFLUENZA; SYSTEM ANALYSIS; TRANSCRIPTOMICS; VIRUS IMMUNITY; ADULT; AGED; BLOOD; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEASON;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; FLOW CYTOMETRY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEASONS; SYSTEMS ANALYSIS; TRANSCRIPTOME;

EID: 84963631903     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.11.012     Document Type: Article

References (55)

1. Abbas A.R., Wolslegel K., Seshasayee D., Modrusan Z., Clark H.F. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS ONE 2009, 4:e6098.
2. Almeida-Oliveira A., Smith-Carvalho M., Porto L.C., Cardoso-Oliveira J., Ribeiro Ados.S., Falcão R.R., Abdelhay E., Bouzas L.F., Thuler L.C.S., Ornellas M.H., Diamond H.R. Age-related changes in natural killer cell receptors from childhood through old age. Hum. Immunol. 2011, 72:319-329.
3. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., Schinzel A.C., Sandy P., Meylan E., Scholl C., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112.
4. Béziat V., Duffy D., Quoc S.N., Le Garff-Tavernier M., Decocq J., Combadière B., Debré P., Vieillard V. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation. J. Immunol. 2011, 186:6753-6761.
5. Bhattacharya S., Andorf S., Gomes L., Dunn P., Schaefer H., Pontius J., Berger P., Desborough V., Smith T., Campbell J., et al. ImmPort: disseminating data to the public for the future of immunology. Immunol. Res. 2014, 58:234-239.
6. Brooks J.P., Lee E.K. Analysis of the consistency of a mixed integer programming-based multi-category constrained discriminant model. Ann. Oper. Res. 2010, 174:147-168.
7. Bucasas K.L., Franco L.M., Shaw C.A., Bray M.S., Wells J.M., Niño D., Arden N., Quarles J.M., Couch R.B., Belmont J.W. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J. Infect. Dis. 2011, 203:921-929.
8. Cao R.G., Suarez N.M., Obermoser G., Lopez S.M., Flano E., Mertz S.E., Albrecht R.A., García-Sastre A., Mejias A., Xu H., et al. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. J. Infect. Dis. 2014, 210:224-233.
9. Clausen J., Vergeiner B., Enk M., Petzer A.L., Gastl G., Gunsilius E. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 2003, 207:85-93.
10. Dreiseitl S., Ohno-Machado L. Logistic regression and artificial neural network classification models: a methodology review. J. Biomed. Inform. 2002, 35:352-359.
11. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., Luster A.D. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 2002, 168:3195-3204.
12. Duraisingham S.S., Rouphael N., Cavanagh M.M., Nakaya H.I., Goronzy J.J., Pulendran B. Systems biology of vaccination in the elderly. Curr. Top. Microbiol. Immunol. 2013, 363:117-142.
13. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
14. Franco L.M., Bucasas K.L., Wells J.M., Niño D., Wang X., Zapata G.E., Arden N., Renwick A., Yu P., Quarles J.M., et al. Integrative genomic analysis of the human immune response to influenza vaccination. eLife 2013, 2:e00299.
15. Frasca D., Diaz A., Romero M., Landin A.M., Phillips M., Lechner S.C., Ryan J.G., Blomberg B.B. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010, 28:8077-8084.
16. Frasca D., Diaz A., Romero M., Landin A.M., Blomberg B.B. High TNF-α levels in resting B cells negatively correlate with their response. Exp. Gerontol. 2014, 54:116-122.
17. Furman D., Jojic V., Kidd B., Shen-Orr S., Price J., Jarrell J., Tse T., Huang H., Lund P., Maecker H.T., et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol. Syst. Biol. 2013, 9:659.
18. Garcia D.M., Baek D., Shin C., Bell G.W., Grimson A., Bartel D.P. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 2011, 18:1139-1146.
19. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., Moser J.M., Mehta R.S., Drake D.R., Castro E., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 2008, 205:3119-3131.
20. Gaujoux R., Seoighe C. CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics 2013, 29:2211-2212.
21. Gorski K.S., Waller E.L., Bjornton-Severson J., Hanten J.A., Riter C.L., Kieper W.C., Gorden K.B., Miller J.S., Vasilakos J.P., Tomai M.A., Alkan S.S. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int. Immunol. 2006, 18:1115-1126.
22. Gracias D.T., Stelekati E., Hope J.L., Boesteanu A.C., Doering T.A., Norton J., Mueller Y.M., Fraietta J.A., Wherry E.J., Turner M., Katsikis P.D. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat. Immunol. 2013, 14:593-602.
23. Haq K., McElhaney J.E. Immunosenescence: Influenza vaccination and the elderly. Curr. Opin. Immunol. 2014, 29:38-42.
24. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
25. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127.
26. Kang I., Hong M.S., Nolasco H., Park S.H., Dan J.M., Choi J.Y., Craft J. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J. Immunol. 2004, 173:673-681.
27. Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559.
28. Li S., Nakaya H.I., Kazmin D.A., Oh J.Z., Pulendran B. Systems biological approaches to measure and understand vaccine immunity in humans. Semin. Immunol. 2013, 25:209-218.
29. Li S., Rouphael N., Duraisingham S., Romero-Steiner S., Presnell S., Davis C., Schmidt D.S., Johnson S.E., Milton A., Rajam G., et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 2014, 15:195-204.
30. Lodish H.F., Zhou B., Liu G., Chen C.Z. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 2008, 8:120-130.
31. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 2013, 31:227-258.
32. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
33. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., Means A.R., Kasturi S.P., Khan N., Li G.M., et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 2011, 12:786-795.
34. Oh J.Z., Ravindran R., Chassaing B., Carvalho F.A., Maddur M.S., Bower M., Hakimpour P., Gill K.P., Nakaya H.I., Yarovinsky F., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014, 41:478-492.
35. Pawelec G., Goldeck D., Derhovanessian E. Inflammation, ageing and chronic disease. Curr. Opin. Immunol. 2014, 29:23-28.
36. Pica N., Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu. Rev. Med. 2013, 64:189-202.
37. Pichichero M.E. Booster vaccinations: can immunologic memory outpace disease pathogenesis?. Pediatrics 2009, 124:1633-1641.
38. Poli A., Michel T., Thérésine M., Andrès E., Hentges F., Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009, 126:458-465.
39. Pulendran B. Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc. Natl. Acad. Sci. USA 2014, 111:12300-12306.
40. Pulendran B., Li S., Nakaya H.I. Systems vaccinology. Immunity 2010, 33:516-529.
41. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., Pirani A., Gernert K., Deng J., Marzolf B., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 2009, 10:116-125.
42. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dörner T., Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006, 6:741-750.
43. Ravindran R., Khan N., Nakaya H.I., Li S., Loebbermann J., Maddur M.S., Park Y., Jones D.P., Chappert P., Davoust J., et al. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 2014, 343:313-317.
44. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809.
45. Sasaki S., Sullivan M., Narvaez C.F., Holmes T.H., Furman D., Zheng N.Y., Nishtala M., Wrammert J., Smith K., James J.A., et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 2011, 121:3109-3119.
46. Seidman J.C., Richard S.A., Viboud C., Miller M.A. Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respi. Viruses 2012, 6:52-62.
47. Shen-Orr S.S., Gaujoux R. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr. Opin. Immunol. 2013, 25:571-578.
48. Simonsen L., Reichert T.A., Viboud C., Blackwelder W.C., Taylor R.J., Miller M.A. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch. Intern. Med. 2005, 165:265-272.
49. Solana R., Campos C., Pera A., Tarazona R. Shaping of NK cell subsets by aging. Curr. Opin. Immunol. 2014, 29:56-61.
50. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
51. Sullivan S.J., Jacobson R., Poland G.A. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev. Vaccines 2010, 9:1127-1133.
52. Tsang J.S., Schwartzberg P.L., Kotliarov Y., Biancotto A., Xie Z., Germain R.N., Wang E., Olnes M.J., Narayanan M., Golding H., et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 2014, 157:499-513. Baylor HIPC Center, CHI ConsortiumCHI Consortium.
53. Wagar L.E., Gentleman B., Pircher H., McElhaney J.E., Watts T.H. Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS ONE 2011, 6:e23698.
54. Walzer T., Dalod M., Robbins S.H., Zitvogel L., Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005, 106:2252-2258.
55. Wang H.B., Wang J.T., Zhang L., Geng Z.H., Xu W.L., Xu T., Huo Y., Zhu X., Plow E.F., Chen M., Geng J.G. P-selectin primes leukocyte integrin activation during inflammation. Nat. Immunol. 2007, 8:882-892.